TickerFacts.

Renalytix plc (RNLXY): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Not updated since 2024-06-30. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$29.24M
Year ended 2024-06-30
2019-06-30: -$42.31M2020-06-30: -$10.24M2021-06-30: -$31.63M2022-06-30: -$52.69M2023-06-30: -$41.71M2024-06-30: -$29.24M-$29.24M
2019-06-30 EBITDA (USD) 2024-06-30
Period endedEBITDAChange YoYSource filing
2024-06-30-$29.24Mn/m2024-09-30, From 2023-07-01
2023-06-30-$41.71Mn/m2024-09-30, From 2022-07-01
2022-06-30-$52.69Mn/m2023-09-28, From 2021-07-01
2021-06-30-$31.63Mn/m2022-10-31, From 2020-07-01
2020-06-30-$10.24Mn/m2022-10-31, From 2019-07-01
2019-06-30-$42.31Mn/a2022-08-01, From 2018-07-01